Focal adhesion kinase autophosphorylation inhibition decreases colon cancer cell growth and enhances the efficacy of chemotherapy

References

• American Cancer Society. Colorectal Cancer Facts & Figures 2011-2013. In: Society AC, ed. Atlanta, 2011.
   Google Scholar
• Golubovskaya VM, Kweh FA, Cance WG. Focal adhesion kinase and cancer. Histol Histopathol 2009; 24:503 - 10; PMID: 19224453
   PubMed Web of Science ®Google Scholar
• Figel S, Gelman IH. Focal adhesion kinase controls prostate cancer progression via intrinsic kinase and scaffolding functions. Anticancer Agents Med Chem 2011; 11:607 - 16; http://dx.doi.org/10.2174/187152011796817646; PMID: 21355844
   PubMed Web of Science ®Google Scholar
• Cance WG, Harris JE, Iacocca MV, Roche E, Yang X, Chang J, et al. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res 2000; 6:2417 - 23; PMID: 10873094
   PubMed Web of Science ®Google Scholar
• Golubovskaya VM, Cance WG. Focal adhesion kinase and p53 signaling in cancer cells. Int Rev Cytol 2007; 263:103 - 53; http://dx.doi.org/10.1016/S0074-7696(07)63003-4; PMID: 17725966
   PubMed Web of Science ®Google Scholar
• Golubovskaya VM, Nyberg C, Zheng M, Kweh F, Magis A, Ostrov D, et al. A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth. J Med Chem 2008; 51:7405 - 16; http://dx.doi.org/10.1021/jm800483v; PMID: 18989950
   PubMed Web of Science ®Google Scholar
• Bolós V, Gasent JM, López-Tarruella S, Grande E. The dual kinase complex FAK-Src as a promising therapeutic target in cancer. Onco Targets Ther 2010; 3:83 - 97; http://dx.doi.org/10.2147/OTT.S6909; PMID: 20616959
   PubMed Web of Science ®Google Scholar
• Golubovskaya VM, Gross S, Kaur AS, Wilson RI, Xu LH, Yang XH, et al. Simultaneous inhibition of focal adhesion kinase and SRC enhances detachment and apoptosis in colon cancer cell lines. Mol Cancer Res 2003; 1:755 - 64; PMID: 12939401
   PubMed Web of Science ®Google Scholar
• Golubovskaya VM, Nyberg C, Zheng M, Kweh F, Magis A, Ostrov D, et al. A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth. J Med Chem 2008; 51:7405 - 16; http://dx.doi.org/10.1021/jm800483v; PMID: 18989950
   PubMed Web of Science ®Google Scholar
• Xu L-H, Yang X, Bradham CA, Brenner DA, Baldwin AS, Craven RJ, et al. The focal adhesion kinase suppresses transformation-associated anchorage-independent apoptosis in human breast cancer cells. J Biol Chem 2000; 275:30597 - 604; http://dx.doi.org/10.1074/jbc.M910027199; PMID: 10777476
   PubMed Web of Science ®Google Scholar
• Golubovskaya VM, Zheng M, Zhang L, Li JL, Cance WG. The direct effect of focal adhesion kinase (FAK), dominant-negative FAK, FAK-CD and FAK siRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis. BMC Cancer 2009; 9:280 - 8; http://dx.doi.org/10.1186/1471-2407-9-280; PMID: 19671193
   PubMed Web of Science ®Google Scholar
• Dikic I, Tokiwa G, Lev S, Courtneidge SA, Schlessinger J. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 1996; 383:547 - 50; http://dx.doi.org/10.1038/383547a0; PMID: 8849729
   PubMed Web of Science ®Google Scholar
• Roberts WG, Ung E, Whalen P, Cooper B, Hulford C, Autry C, et al. Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271. Cancer Res 2008; 68:1935 - 44; http://dx.doi.org/10.1158/0008-5472.CAN-07-5155; PMID: 18339875
   PubMed Web of Science ®Google Scholar
• Halder J, Lin YG, Merritt WM, Spannuth WA, Nick AM, Honda T, et al. Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma. Cancer Res 2007; 67:10976 - 83; http://dx.doi.org/10.1158/0008-5472.CAN-07-2667; PMID: 18006843
   PubMed Web of Science ®Google Scholar
• Wang ZG, Fukazawa T, Nishikawa T, Watanabe N, Sakurama K, Motoki T, et al. TAE226, a dual inhibitor for FAK and IGF-IR, has inhibitory effects on mTOR signaling in esophageal cancer cells. Oncol Rep 2008; 20:1473 - 7; PMID: 19020730
   PubMed Web of Science ®Google Scholar
• Tanjoni I, Walsh C, Uryu S, Tomar A, Nam JO, Mielgo A, et al. PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments. Cancer Biol Ther 2010; 9:764 - 77; http://dx.doi.org/10.4161/cbt.9.10.11434; PMID: 20234191
   PubMed Web of Science ®Google Scholar
• Beierle EA, Ma X, Stewart J, Nyberg C, Trujillo A, Cance WG, et al. Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma. Cell Cycle 2010; 9:1005 - 15; http://dx.doi.org/10.4161/cc.9.5.10936; PMID: 20160475
   PubMed Web of Science ®Google Scholar
• Hochwald SN, Nyberg C, Zheng M, Zheng D, Wood C, Massoll NA, et al. A novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer. Cell Cycle 2009; 8:2435 - 43; http://dx.doi.org/10.4161/cc.8.15.9145; PMID: 19571674
   PubMed Web of Science ®Google Scholar
• Topley P, Jenkins DC, Jessup EA, Stables JN. Effect of reconstituted basement membrane components on the growth of a panel of human tumour cell lines in nude mice. Br J Cancer 1993; 67:953 - 8; http://dx.doi.org/10.1038/bjc.1993.176; PMID: 8494729
   PubMed Web of Science ®Google Scholar
• Trainer DL, Kline T, McCabe FL, Faucette LF, Feild J, Chaikin M, et al. Biological characterization and oncogene expression in human colorectal carcinoma cell lines. Int J Cancer 1988; 41:287 - 96; http://dx.doi.org/10.1002/ijc.2910410221; PMID: 3338874
   PubMed Web of Science ®Google Scholar
• Parsons JT, Slack-Davis J, Tilghman R, Roberts WG. Focal adhesion kinase: targeting adhesion signaling pathways for therapeutic intervention. Clin Cancer Res 2008; 14:627 - 32; http://dx.doi.org/10.1158/1078-0432.CCR-07-2220; PMID: 18245520
   PubMed Web of Science ®Google Scholar
• Beierle EA, Ma X, Trujillo A, Kurenova EV, Cance WG, Golubovskaya VM. Inhibition of focal adhesion kinase and src increases detachment and apoptosis in human neuroblastoma cell lines. Mol Carcinog 2010; 49:224 - 34; PMID: 19885861
   PubMed Web of Science ®Google Scholar
• Schlaepfer DD, Hauck CR, Sieg DJ. Signaling through focal adhesion kinase. Prog Biophys Mol Biol 1999; 71:435 - 78; http://dx.doi.org/10.1016/S0079-6107(98)00052-2; PMID: 10354709
   PubMed Web of Science ®Google Scholar
• Talpaz M, Shah NP, Kantarjian H, Donato N, Nicoll J, Paquette R, et al. Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias. N Engl J Med 2006; 354:2531 - 41; http://dx.doi.org/10.1056/NEJMoa055229; PMID: 16775234
   PubMed Web of Science ®Google Scholar
• Heffler M, Golubovskaya VM, Cance WG, Bullard Dunn KM. Evolving molecular therapeutics and their applications to surgical oncology. American College of Surgeons: Principles and Practice. Chicago (IL): American College of Surgeons, 2011.
   Google Scholar
• Lai E, Singh R, Teng B, Zhao Y, Sharratt E, Howell G, et al. Inhibition of hyaluronan synthase-3 decreases subcutaneous colon cancer growth in mice. Dis Colon Rectum 2010; 53:475 - 82; http://dx.doi.org/10.1007/DCR.0b013e3181c87084; PMID: 20305449
   PubMed Web of Science ®Google Scholar